Limited evidenceWomen's health

Uva Ursi

Uva ursi (bearberry) has been tested head-to-head as an antibiotic-sparing treatment for uncomplicated UTI and lost — worse symptom resolution and more cases of pyelonephritis in the herbal arm. Its hydroquinone content also caps safe use at about a week.

What the science says

Treats uncomplicated UTI as an antibiotic alternative Limited evidence
A randomized trial in German primary care compared uva ursi extract with single-dose fosfomycin in 398 women with uncomplicated UTI. Uva ursi reduced antibiotic use but produced worse symptom resolution and more cases of pyelonephritis in the herbal arm, leading the investigators to conclude it cannot be recommended as an antibiotic alternative. That is a safety signal, not just an efficacy failure.
Shortens UTI symptom duration Limited evidence
The ATAFUTI factorial randomized trial in 382 women found uva ursi did not significantly reduce the duration of moderately bad urinary symptoms compared with placebo, although there was a small reduction in subsequent antibiotic consumption. Ibuprofen advice, the other factor in the trial, had a clearer effect on antibiotic use than the herb did.
Prevents recurrent UTIs Limited evidence
There is essentially no modern prophylaxis evidence, and the hydroquinone exposure that arbutin metabolism produces makes long-term daily use inadvisable anyway. Traditional dosing guidance explicitly caps courses at a week or so, which rules out the continuous use that prophylaxis requires.

Dosage & safety

Studied dosePreparations are standardized to arbutin, with trials and traditional monographs using roughly 400-840 mg arbutin/day in divided doses. Use is limited to no more than 7-10 days per course and no more than about 5 courses per year, per German Commission E-style guidance. Some traditions recommend alkalinizing the urine to favor hydroquinone activity, but this is not supported by trial data.

SafetyArbutin is metabolized to hydroquinone, which is why duration is restricted: hydroquinone is associated with liver toxicity, retinal changes with chronic exposure, and is a suspected carcinogen at sustained doses. Short courses commonly cause nausea, vomiting, and greenish-brown urine discoloration (harmless). Contraindicated in pregnancy (uterine stimulant reports) and breastfeeding, in children, in kidney or liver disease, and alongside other hepatotoxic agents. Do not use for a febrile UTI, flank pain, or suspected pyelonephritis — the fosfomycin comparison trial found more upper-tract infections in the uva ursi arm. In several countries uva ursi products carry restricted-duration labelling.

Scientific references

Herbal treatment with uva ursi extract versus fosfomycin in women with uncomplicated urinary tract infection in primary care: a randomized controlled trial
Gágyor I, Hummers E, Schmiemann G, Friede T, Pfeiffer S, Afshar K, Bleidorn J — Clinical Microbiology and Infection, 2021
Uva-ursi extract and ibuprofen as alternative treatments for uncomplicated urinary tract infection in women (ATAFUTI): a factorial randomized trial
Moore M, Trill J, Simpson C, Webley F, Radford M, Stanton L, Maishman T, Galanopoulou A, Flower A, Eyles C, Willcox M, Hay AD, van der Werf E, Gibbons S, Lewith G, Little P, Griffiths G — Clinical Microbiology and Infection, 2019

Where to buy

Solaray, True Herbs, Uva Ursi, 460 mg, 100 VegCaps

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Women's health

Folic Acid (Vitamin B9) Strong evidence
Inositol (Myo-Inositol) Moderate evidence
Strontium Limited evidence
Soy Isoflavones Moderate evidence
Ipriflavone Limited evidence
Evening Primrose Oil Limited evidence